Tr1X Inc.

About Tr1X Inc.

Tr1X is a biotechnology company focused on developing a novel class of regulatory T cell-based therapies to cure autoimmune and inflammatory diseases, aiming to restore immune tolerance and transform patient lives.

Products & Services

Regulatory T Cell-Based Therapeutics:Designed to mimic naturally occurring Type 1 regulatory T (Tr1) cells, these products aim to restore immune tolerance and stop severe autoimmune and inflammatory diseases.

TRX103:A therapy in Phase 1/2a clinical trials for Graft Versus Host Disease, supported by a significant grant.

Specialties

Regulatory T Cell-Based Therapies Autoimmune Diseases Inflammatory Diseases Genetic Engineering Cellular Therapies

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Grant T: - FT: Grant	A: 8000000 MR: - FA: $8 million FAN: 8000000	D: 2025-04-04 FD: 2025-04-04	1 investors
2	RT: Series A T: - FT: Series A	A: 75000000 MR: - FA: $75 million FAN: 75000000	D: 2024-01-17 FD: 2024-01-17	3 investors

Grant Latest

2025-04-04

$8.0M

1 investor (Pro only)

Series A 2024-01-17

$75.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

B

Bill Lis

Executive Chairman

D

David de Vries

Co-founder, Chief Executive Officer

LinkedIn (Pro only)

M

Maria Grazia Roncarolo

Co-founder, President and Head of R&D

LinkedIn (Pro only)

J

Jonathan Perrin

Co-founder, General Counsel

M

Marco Londei

Chief Medical Officer

J

James Adams

Chief Technical Officer

View 14 more team members with Pro

Unlock Full Team Directory

Recent News

Tr1X Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised